New study identifies more people with vision loss and blindness than previously estimated

New study identifies more people with vision loss and blindness than previously estimated


In a study published in JAMA Ophthalmology today, “Prevalence of Visual Acuity Loss or Blindness in the US,” researchers estimate permanent vision loss and blindness in Americans of all ages, including people younger than 40 years old, and adults in group quarters, such as nursing homes or jails.  Researchers found more than 7 million people are living with uncorrectable vision loss, including more than one million Americans who are living with blindness.

“What makes this study different than previous national estimates of vision loss and blindness is that the methods we used allowed for a broader analysis of populations in the United States than were previously included,” said David B. Rein, Ph.D., Program Area Director for NORC at the University of Chicago’s Public Health Analytics Program and one of the study’s co-authors. “While the addition of these various age groups is partially responsible for the increase, the growth in the number of older Americans has also contributed to more people with vision loss and blindness in the United States than previously estimated.”

Additional findings from the study include:

  • Of those living with vision loss and blindness in the United States, nearly 1 in 4 are under the age of 40.
    • More than 1.6 million Americans who are living with vision loss or blindness are under the age of 40.
    • Of them, 141,000 are blind, 13% of all people with blindness in the U.S.
  • 358,000 people with vision loss and blindness are living in group quarters, such as nursing homes or jails.
    • Of them 130,000 are living with blindness, representing nearly 12% of people living with blindness.
  • In the United States:
    • 20% of all people aged 85 and older experience permanent vision loss.
    • More females than males experience permanent vision loss or blindness.
    • There is a higher risk of vision loss among Hispanic/Latino and Black people than among Whites.

“Prevalence of Visual Acuity Loss or Blindness in the US,” was authored by researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington (Seattle), NORC at the University of Chicago (NORC), and the Centers for Disease Control and Prevention’s (CDC) Vision Health Initiative, with support from Prevent Blindness.

“Vision loss and blindness are often preventable.  Vision loss is heavily influenced by access to eye care, general health care, geography, race/ethnicity, sun exposure, and underlying health conditions, like diabetes,” said study co-author, Elizabeth Lundeen, PhD, MPH, epidemiologist, CDC. “These updated estimates help us better understand the problem, allow for strategic resource allocation, the development and implementation of policies and programs to reduce the burden of vision loss and blindness in the United States.”

Study estimates were developed using data within CDC’s Vision and Eye Health Surveillance System (VEHSS). The VEHSS houses diverse data sources for vision – including Medicare and private insurance claims data, electronic health record data, and self-reported and clinical evaluation data from representative national surveys. Researchers used a statistical methodology called Bayesian meta-regression which used the system’s multiple data sources to produce new, more comprehensive national and state-level estimates of vision loss and blindness.

Prevent Blindness, a primary stakeholder in the study, serves as an engagement and communication channel for the VEHSS, working directly with NORC, CDC, and other partners.

Three-Day virtual extension of the Vision Expo East 2021 experience

Three-Day virtual extension of the Vision Expo East 2021 experience

The Vision Council and Reed Exhibitions, the organizers of Vision Expo, announced Vision Expo+, a free digital extension of the Vision Expo East experience that will be offered from June 3–5 in conjunction with Vision Expo East 2021 through ShopVISION, a new global sourcing platform.

Vision Expo+ reflects an effort by the Show organizers to accommodate members of the vision care community from around the globe by providing more ways for the community to experience Vision Expo East, taking place June 2–5 in Orlando.
From June 3–5, Vision Expo+ will offer a number of virtual experiences, including online showrooms from Vision Expo East’s more than 200 exhibitors and livestreamed Vision Expo East content. All events taking place at The Seen, a dynamic new main stage destination for collaborative learning, including EYE2EYE Series discussions, will be simulcast live on the ShopVISION platform. Additionally, the recorded sessions will be available to view on ShopVISION starting Monday, June 7.

To gain access to all Vision Expo+ offerings, register for ShopVISION  by clicking the “Sign in/Join” button and then “Register Now.” ShopVISION and Vision Expo+ are being offered on a complimentary basis to all eyecare providers, buyers and all Vision Expo East 2021 exhibitors.
Registration is now open and access to the ShopVISION platform will open on Thursday, June 3. Following the conclusion of Vision Expo+, registrants will continue to have access to ShopVISION.

EssilorLuxottica presents its new Board of Directors

EssilorLuxottica presents its new Board of Directors

During EssilorLuxottica’s annual General Meeting shareholders approved all the names of the proposed directors who now sit on the new Board of Directors of the Company, including: Mr. Leonardo Del Vecchio, Mr. Francesco Milleri, Mr. Paul du Saillant, Mr. Romolo Bardin, Mr. JeanLuc Biamonti, Ms. MarieChristine CoisneRoquette, Ms. Juliette Favre, Mr. José Gonzalo, Ms. Swati Piramal, Ms. Cristina Scocchia, Ms. Nathalie von Siemens and Mr. Andrea Zappia.

During the meeting, the Board of Directors appointed Mr. Leonardo Del Vecchio as Chairman of the Board, Mr.Francesco Milleri as CEO and Mr. Paul du Saillant as Deputy CEO of EssilorLuxottica. In the same meeting, the Board of Directors has been informed of the appointment of Mr.Stefano Grassias the CFO of the Company.

I want to thank the board members and the entire Company for trusting in me and our outstanding executive team. I am very pleased to continue working with Paul to lead EssilorLuxottica into its next chapter, where we will reach new heights while creating value for all our stakeholders. Beside us, we will have the thousands of talented women and men whose contributions will allow us to deliver on our inspiring Mission to help people see more, be more and live life to its fullest”, commented Francesco Milleri, CEO of EssilorLuxottica.

I am very honored to have been appointed as Deputy CEO of this wonderful company, and would like to express my gratitude to the Chairman and the entire Board. In the past year, we have demonstrated EssilorLuxottica’s strong resilience and growth potential. I look forward to continuing to work alongside Francesco and our 140,000 employees to combine and leverage our unique assets, for the benefit of our customers and consumers,” commented Paul du Saillant, Deputy CEO of EssilorLuxottica.

FDA has granted “Breakthrough Device” designation to Essilor´s Stellest spectacle lens

FDA has granted “Breakthrough Device” designation to Essilor´s Stellest spectacle lens

Picture by Paul Diaconu on Pixabay

Essilor announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Devicedesignation to its Essilor Stellest spectacle lens, the Company’s new generation lens developed to correct myopia and slow down the progression of myopiain children.

The designation of the Essilor’s Stellest spectacle lens as by the FDA, that will lead to further U.S. research and FDA review, builds on the publication of twoyear results of an ongoing threeyear clinical trial, in China, in myopic children. After the first year, the trial results demonstrated that the eye growth of 9 out of 10 children wearing the Essilor Stellest lens was similar or slower than nonmyopic children. While after two years, according to Essilor, Essilor Stellest lens has been proven to be among the most effective myopia control solutions which have ever been tested.

“The Breakthrough Devicedesignation for ourEssilor Stellest lens is a great achievement and an illustration of its potential in slowing down the progression of myopia in children. This designation represents an important milestone in our fight against the myopia pandemic. We look forward to working closely with the FDA for further clinical study and review, so we can provide the benefit of Essilor Stellest to U.S. children who continue to be at risk of visionthreatening complications due to high myopia.” commented Norbert Gorny, Chief Operating Officer and Chief Research & Development Officer of Essilor International.

The Breakthrough Devices Program by the FDA is intended to provide patients and health care professionals with timely access to medical devices that offer more effective treatment or diagnosis of lifethreatening or irreversibly debilitating diseases or conditions by speeding up their development, assessment, and review. After successful launch in China and other countries since 2020 with extremely positive response from eye care professionals, Essilor intends to further roll out Essilor Stellest in other countries

Mido presents 2021 digital edition concept

Mido presents 2021 digital edition concept

A general view of MIDO 2019 (Photo by Tullio M. Puglia/Getty Images for MIDO)

Today, the Mido organizers presented the concept of the digital Mido 2021. It will take place from Saturday 5 to Monday 7 June. The international eyewear event goes on stage with an exceptional edition: a June appointment instead of the usual February dates and a virtual first, with a new 360° format that will bring an innovative experience, thanks to the new platform debuting on 28 May. All in anticipation of the face-to-face edition at Rho Fiera from 12 to 14 February 2022.

The Mido 2021 | Digital Edition has several opportunities and initiatives in store: a special show “A new way of seeing” will open the event on June 5 with a notable guest; the photographer Albert Watson who, from his point of view, will narrate the transformative moment the world is going through and the new ways of seeing everything that surrounds us: beauty, living together, nature, technology, and the future.

The Mido organizers presented the concept for the digital Mido in June.

The event scheduled for June 6 goes to the heart of Mido, addressing two fundamental aspects of the eyewear industry: fashion and design through the encounter of five talents from different worlds, four successful representatives of the fashion world and four promising designers in the sector.

Once again, this year sees plenty of appointments with WGSN: Future Consumer 2022, Millennial and Genx Priorities, The Future Shopper and Eyewear Trends. A particular emphasis will be placed on innovative and eco-sustainable materials thanks to the contribution of Materially and the three events scheduled during the tradeshow: Biomaterially, Transformed Waste, Perfect beauty.

Stands, lounges and rooms become virtual, seven days a week, 24 hours a day: spaces for public engagement that, until 31 December, will offer events, meetings, and business opportunities, with the exhibition of products and the possibility of online trading.
The BeStore Award will be enriched with a new category. This year, in addition to the design and innovation prizes awarded by an international panel of experts, the Your BeStore award will also be presented, giving all visitors the chance to vote for their favourite optical centre through the platform.

All updates on the event will be available online on the website and the official social media channels: Instagram (@mido_exhibition), Facebook (@MIDOExhibition), Twitter (@MIDOExhibition) and Linkedin and through the official APP.